SOLIGENIX, INC. — Director's Dealing 2009

Jul 9, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DOR BIOPHARMA INC (DORB)
CIK: 0000812796
Period of Report: 2009-06-04

Reporting Person: Buhrman Cyrille F (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-06-04	Stock Options (right to buy)	$0.14	A	250000	Acquired	2019-06-03	Common Stock (250000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4900020	Direct

Footnotes

F1: Stock options awarded for re-election to the Board of Directors.